12:00 AM
Jul 30, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

ARCHITECT Galectin-3 Assay regulatory update

BG Medicine submitted a 510(k) application to FDA for its ARCHITECT Galectin-3 Assay. The test measures a patient's blood level of galectin-3 (LGALS3) and...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >